Related Experiment Video
Updated: Jun 4, 2026

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics
Published on: May 14, 2016
GRP78/BiP modulation of GRP78/BiP in altering sensitivity to chemotherapy
1Department of Neurosurgery and Pathology, University of Southern California, Los Angeles, USA.
Abstract:
The glucose-regulated protein 78 (GRP78) is a key regulator of the endoplasmic reticulum (ER) stress response. This chapter discusses how GRP78 may be measured in vitro and in vivo. Because of the authors' expertise and experience with brain tumors, most of our work on GRP78 has focused on malignant gliomas. Here, we present our methodology for determining GRP78 in vitro using glioma cell lines and primary cell cultures, and in measuring GRP78 expression in tissue sections from rodent glioma models and human brain tumors. After discussion of measurement of GRP78 levels, modulation of GRP78 in vitro is demonstrated using glioma cell lines. Lastly, in vivo modulation of GRP78 levels via chemotherapy is determined using intracranial rodent models.
Related Concept Videos
Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
Receptor Downregulation in MVBs
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
Abnormal Proliferation
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
The Intrinsic Apoptotic Pathway